Oxford Funding Corp.

Public Company, Headquarters Location
1240 Blalock Rd., Ste. 210, Houston, TX 77055-6443, United States
(713)975-9602, (713)978-6292 fax, http://www.oxfordfunding.com

Primary SIC: Investors, Not Elsewhere Classified, Primary NAICS: Miscellaneous Financial Investment Activities
Description: Finance: Subprime mortgage portolio trading.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Oxford Funding Corp., News and Information

Other News To Note.
BIOWORLD Today; 11/4/2009; 1075 words; Aphton Corp., of Miami, filed...purposes, including funding ongoing trials and operations...to close at 10 cents. Oxford GlycoSciences plc, of Oxford UK, and the Cystic Fibrosis...Montreal, and Chiron Corp., of Emeryville, Calif...

Ribozyme Regains Herzyme Control After Elan Backs Out.
BIOWORLD Today; 11/4/2009; 1088 words; ...Dublin, Ireland-based Elan Corp. plc, Ribozyme Pharmaceuticals...Venrock Associates, of New York; Oxford Bioscience Partners, of Boston...split plus the $48 million funding combined would put us well over...the pipeline, RPI and Chiron Corp., of Emeryville, Calif...

$300 million Oxford trail leads into Canada; Regulators are investigating whether a Toronto firm aided a suspect currency program.(BUSINESS)
Star Tribune (Minneapolis, MN); 11/4/2009; 1291 words; ...KINGZ Capital Management Corp. -- is the largest...KINGZ Capital Management Corp. and David M.S. Krywenky...them with start-up funding. Alvarez has since disappeared...several businesses with Oxford or Universal Brokerage...said it learned that Oxford Global Partners, a firm...

Altor Moving To Clinic With T-Cell Receptor-Based Drug.
BIOWORLD Today; 11/3/2009; 1093 words; ...ago, Altor BioScience Corp. has made steady progress...from Sunol Molecular Corp., previously was the subject of Phase I SBIR funding, and has shown an ability...fairly young field. Oxford, UK-based Avidex Ltd...received its initial funding from Sunol, and later...

Dynogen's GI, GU Products To Benefit From $50M Round.
BIOWORLD Today; 11/3/2009; 1216 words; ...Tokyo-based Mitsubishi Pharma Corp. Dynogen holds all clinical...Lorette said. Boston-based Oxford Bioscience Partners provided seed funding for the company in May 2002...Existing investors included Oxford BioScience; HealthCare Ventures...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.